Sensitization to the locomotor stimulant activity of cocaine is associated with increases in nitric oxide synthase activity in brain regions and spinal cord of mice

Pharmacology

Volumn 55, Issue 6, 1997, Pages 292-298

  Bhargava, Hemendra N ^a   Kumar, Shailendra ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Brain regions; Cocaine, sensitization; Nitric oxide synthase; Spinal cord Mouse

Indexed keywords

COCAINE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG SENSITIZATION; DRUG WITHDRAWAL; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MESENCEPHALON; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030729452     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139541     Document Type: Article

References (30)

1. Drug Abuse Warning Network (DAWN). National Household Survey Data. Department of Health and Human Services, Rockville. 1992.
2. Satel SL. Southwick SVI, Gawin FH: Clinical features of cocaine-induced paranoia. Am J Psychiatry’ 1991: 148:495-498.
3. Haracz JL. Belanger SA. MacDonall JS, Sircar R: Antagonists of N-meth-yl-D-aspartate receptors partially prevent the development of cocaine sensitization. Life Sci 1995:57: 2347-2357.
4. Itzhak Y: Nitric oxide (NO) synthase inhibitors abolish cocaine-induced toxicity in mice. Ncurophar-macologv 1993;32:1069-1070.
5. Itzhak Y: Modulation of the PCP/ NMDA receptor complex and 8 binding sites by psychostimulants. Neurotoxicol Teratol 1994; 16:363-368.
6. Kalivas PW. Alcsdatter JE: Involvement of N-methyl-U-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol ExpTher 1993:267:486-495.
7. Karler R. Caldcr LD. Chaudhry IA, Turkanis SA: Blockade of ‘reverse tolerance’ to cocaine and amphetamine by MK-801. LifeSci 1989:45: 599-606.
8. Kim HS. Park WK: Nitric oxide mediation of cocaine-induced dopaminergic behaviors: Ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice. J Pharmacol Exp Ther 1995: 275:551-557.
9. Post RM. Lockfeld A. Squillace KM. Contel NR: Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization. Life Sci 1981:28:755-760.
10. Pudiak CM. Bozarth MA: L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci 1993:53:1517-1524.
11. Wolf ME, Jeziorski M: Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization to amphetamine. J Ncu-rosci 1993:14:291-294.
12. Moncada S, Higgs EA: Endogenous nitric oxide: Physiology, pathology and clinical relevance. Eur J Clin Invest 1991:21:361-374.
13. Ida I. Asami T. Kuribara H: Inhibition of cocaine sensitization by MK-801. a non-competitive N-mcthyl-D-aspartate (NMDA) receptor antagonist: evaluation by ambulatory activity in mice. Jpn J Pharmacol 1995:69:83-90.
14. Itzhak Y: Blockade of sensitization to the toxic effects of cocaine in mice by nitric oxide synthase inhibitors. Pharmacol Toxicol 1994:74 162-166.
15. Przcwlocka B. La son W. Machclska H. Przewlocki R: The effects of cocaine-induced seizures on the procn-kenphalin mRNA level in the mouse hippocampus: A possible involvement of the nitric oxide pathway. NeurosciLett 1994:168:81-84.
16. Haracz JL. MacDonall JS. Sircar R: Effects of nitric oxide synthase inhibitors on cocaine sensitization. Brain Res 1997:746:183-189.
17. Barjavel MJ, Bhargava HN: Effect of morphine tolerance and abstinence on nitric oxide synthase activity in brain regions and spinal cord of the mouse. Soc Neurosci Abstr 1994;20:A1234.
18. Barjavel MJ. Bhargava HN: Effect of opioid receptor agonists on nitric oxide synthase activity in rat cerebral cortex homogenate. Neurosci Lett 1994:188:27-30.
19. Lowry OH. Roscbrough NJ. Farr AL. Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951:193:265-275.
20. Kalivas PW. Steward J: Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res Rev 1991; 16:223-244.
21. Bradberry CW. Roth RH: Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci Lett 1989; 103:97-102.
22. Kuczenski R. Segal D: Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 1989:372:21-30.
23. Zhu XZ. Luo LG: Effect of nitro-prusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J Ncurochcm 1992: 59:932-935.
24. Garthwaite J. Gartlnvaite G, Palmer RM. Moncada S: NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 1989:172: 413-416.
25. Sivam SP: Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanisms. J Pharmacol Exp Ther 1989;250: 818-824.
26. Smiley PL. Johnson M. Bush L. Gibb JW. Hanson GR: Effects of cocaine on extrapyramidal and limbic dynorphin systems. J Pharmacol ExpTher 1990:253:938-943.
27. Steiner H, Gerfen CR: Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J Neurosci 1993: 13:5066-5081.
28. Dunais JB, McGinty JF: Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAS. Synpase 1994;18:35-45.
29. Unterweld EM. Rubenfeld JM, Kreek MJ: Repeated cocaine administration upregulates k and p. but not 8-, opioid receptors. Neurorc-pori 1994;5:1613-1616.
30. Heidbreder C. Goldberg SR. Ship-penberg TS: Inhibition of cocaine-induced sensitization by the 8-opioid receptor antagonist nallrin-dole. Eur J Pharmacol 1993:243: 123-127